Filing Details

Accession Number:
0001437749-23-002930
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-09 19:01:06
Reporting Period:
2023-02-07
Accepted Time:
2023-02-09 19:01:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
834365 Biolife Solutions Inc BLFS Electromedical & Electrotherapeutic Apparatus (3845) 943076866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1633186 Todd Berard C/O Biolife Solutions, Inc.
3303 Monte Villa Parkway, Suite 310
Bothell WA 98021
Chief Marketing Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-07 1,000 $2.06 120,265 No 4 M Direct
Common Stock Disposition 2023-02-07 1,000 $25.29 119,265 No 4 S Direct
Common Stock Acquisiton 2023-02-08 9,000 $2.06 128,265 No 4 M Direct
Common Stock Disposition 2023-02-08 9,000 $25.13 119,265 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-02-07 1,000 $0.00 1,000 $2.06
Common Stock Stock Option (Right to Buy) Disposition 2023-02-08 9,000 $0.00 9,000 $2.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,000 2016-05-04 2025-05-04 No 4 M Direct
30,000 2016-05-04 2025-05-04 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16.